Hologic Forecast, price target & analysts
Hologic Target price 2025 - Analyst rating & recommendation
Hologic Classifications & Recommendation:
Hologic Price Target
| Target Price | $77.01 |
| Price | $74.11 |
| Potential |
3.91%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Hologic 2026 .
The average Hologic target price is $77.01.
This is
3.91%
register free of charge
$81.90
10.51%
register free of charge
$69.69
5.96%
register free of charge
|
|
| A rating was issued by 25 analysts: 9 Analysts recommend Hologic to buy, 16 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hologic stock has an average upside potential 2026 of
3.91%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.10 | 4.36 |
| 1.74% | 6.23% | |
| EBITDA Margin | 23.98% | 32.48% |
| 3.31% | 35.46% | |
| Net Margin | 13.80% | 23.54% |
| 29.57% | 70.63% |
22 Analysts have issued a sales forecast Hologic 2026 . The average Hologic sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Hologic EBITDA forecast 2026. The average Hologic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Hologic Analysts have issued a net profit forecast 2026. The average Hologic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.49 | 4.61 |
| 25.00% | 85.14% | |
| P/E | 16.09 | |
| EV/Sales | 3.86 |
22 Analysts have issued a Hologic forecast for earnings per share. The average Hologic EPS is
This results in the following potential growth metrics and future valuations:
Current Hologic Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Oct 21 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
